Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-03-23

Clinical Trial Update: Opioid Use Disorder Treatment Linkage at Sexual Health Clinics Using Buprenorphine [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update investigating linkage to opioid use disorder treatment at sexual health clinics using buprenorphine, currently in Phase 2/Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • buprenorphine (buprenorphine)

Snippet

Sponsor: Friends Research Institute, Inc. | Conditions: Opioid-use Disorder | Phase 2, Phase 3 | Status: UNKNOWN